Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Derek Sheader
Latest news
-
From curiosity to career: LifeArc placement students share their stories for British Science Week
-
First projects backed by C-Further consortium to develop better treatments for children with cancer
-
International Women’s Day 2026: Stories of support, confidence and paying it forward